NewAmsterdam Pharma (NAMS)
NewAmsterdam Pharma (NAMS) on the public record today: 1 item across Short interest, each linked to its public source.
Last updated: .
Short interest
- NAMS: shares sold short down 26% to 14.1M at the 15 Oct settlement — 19.0M at the previous settlement · 10.6 days to cover · shares sold short and not yet bought back, as FINRA member firms reported them (FINRA (equity short interest), 14 Oct 2026) NAMS